Cigna expands purview of global CIO
Noelle Eder, who first joined the company in August 2020, will add data and analytics to her role.
6 drug companies could face steep fines for violating 340B law
The ongoing refusal of Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi and United Therapeutics to offer discounts to safety-net providers through community pharmacy partnerships has been referred to OIG for enforcement.
CDC recommends Pfizer booster shots for many, overruling advisers on broad use
Though an agency panel voted against advising a third Pfizer vaccine dose for younger people in high-risk jobs like nursing or teaching, it was overriden by CDC Director Rochelle Walensky.
Centene, Humana sue Merck for ‘monopolistic scheme’ to delay generics of blockbuster cholesterol drug
The suits allege an agreement between Merck and a generic manufacturer kept lower-cost versions of the drugmaker’s widely used pill Zetia off the market for years.
Quarter of providers saw mortality rates rise after ransomware attacks, survey finds
This study of health delivery organizations is one of the first finding a direct impact on patient care down the line, and comes roughly a year after a patient in Germany died as a result of delayed care following a ransomware attack.
Sutter kicks off nationwide CEO search as Sarah Krevans announces retirement
Whoever replaces Krevans will inherit a difficult financial situation, shaky relations with worker groups and a brand marred by several recent legal disputes with the federal government.
State Medicaid officials face daunting fall amid low vaccination rates, record enrollment
Telehealth and behavioral health service needs are also a challenge as the COVID-19 pandemic drags on and the Biden administration encourages more people to get on the rolls.
FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans
The authorization is more narrow than envisioned by the Biden administration last month, but still makes potentially millions of Americans eligible for a third Pfizer shot.
Payers double down on population health programs amid COVID-19
Keys to successful interventions include good data, local connections and realistic ROI expectations, payer executives said Tuesday at AHIP’s annual conference on Medicare, Medicaid and dual eligibles.
OIG flags potential $5B overpaid to Medicare Advantage plans
The watchdog calls out 20 private insurers, which it does not name, and urges CMS to conduct greater oversight.